Related articles

anti-obesity drug market

Market for obesity treatments estimated to exceed $100 billion by 2030, with Novo Nordisk and Eli Lilly competing and developing next-generation treatments.

• The Icelandic DNA Behind Amgen’s Bid for the Next Ozempic
• Wegovy Pill Arrives in French Pharmacies as Obesity Drug Competition Heats Up